Hunan Warrant Pharmaceutical

Hunan Warrant Pharmaceutical is a China-based, innovation-driven pharmaceutical manufacturer focused on chemical drugs, traditional Chinese medicine products, APIs, intermediates, and selected biologics. Founded in 2001 and listed on the Shanghai Stock Exchange STAR Market in 2021, the company operates an integrated model spanning R&D, manufacturing, and commercialization, with strengths in API-to-formulation integration and specialty product platforms. Its marketed portfolio covers digestive, respiratory, anti-infective, cardiovascular, cerebrovascular, diabetes, and pediatric-related products, while its development pipeline includes innovative antidepressant and traditional Chinese medicine assets as well as a broad base of generic and reformulated programs. The company also maintains export-oriented API and excipient capabilities and has disclosed multiple GMP and regulatory milestones supporting international expansion. In addition to commercial products, it is building differentiated platforms in chiral chemistry, inhalation delivery, micropellets, bismuth products, and specialty TCM-derived products.